InfectoGnostics

InfectoGnostics

Breaking New Ground in Diagnostics of Infections

As a public-private partnership, the InfectoGnostics Research Campus Jena is breaking new ground in the diagnosis of infections. More than 30 partners from science, medicine and industry are working together to develop innovative solutions for the rapid and cost-effective on-site diagnosis of infectious diseases. As an Thuringian innovation cluster, InfectoGnostics is deeply rooted in Thuringia's innovation landscape and is also well connected with other clusters, commercial enterprises, research institutions, clinics and other stakeholders both nationally and internationally.

Read more our mission and the concept of our campus.

News

Find out more about current advancements in diagnostics and infection research in our most recent news or browse through our news archive.

Multi-Million Investment in Thuringian Startups: Three InfectoGnostics Partners Secure Funding Rounds

applyo Jena, DeepEn, and Fluidect – three dynamic startups from the InfectoGnostics Research Campus Jena have successfully closed funding rounds to further develop their technologies and accelerate market entry. These companies exemplify the successful transfer of cutting-edge research into commercial applications.

Read more

SESSION "TECHNOLOGY CORNER IN DIAGNOSTICS" AT AMR-CONFERENCE 2025 IN BASEL

The upcoming AMR Conference will feature a pivotal session moderated by Jens Hellwage (InfectoGnostics Research Campus Jena) and supported by the Thuringian Cluster Management.

Read more

Anonymization for secure data use - AVATAR contributions to AnoSiDat congress in Lübeck

About 200 participants, including researchers, guests and interested members of the public, came together at media docs in Lübeck from 16 to 17 April to discuss the anonymization of personal data

Read more

InfectoGnostics and partners at the German Biotechnology Days 2024 in Berlin

At the DBT 2024, the InfectoGnostics research campus once again presented Thuringian technologies and products for the fields of biotechnology, diagnostics and medical technology.

Read more

Events

Here you will find the current events in our network as well as an overview of previous events that have already taken place.

No news available.

Projects

  • InfectoXplore

    Spektroskopische Plattform zur Diagnostik von Infektionen aus Blut

    Mit „InfectoXplore“ wird am InfectoGnostics Forschungscampus eine Diagnostik-Plattform aufgebaut, mit der erstmals auch aus Blutkulturen eine umfassende Raman-spektroskopische Erreger-Analyse durchgeführt werden kann.

    Find out more about InfectoXplore.

  • Resistovac

    Testformate zur schnellen Erfassung des Impfstatus

    Im Projekt „RESISTOVAC“ werden verschiedene Testformate entwickelt, die zur schnellen Erfassung des Impfstatus von Menschen und Tieren eingesetzt werden können und so entscheidend zur Prävention von Infektionskrankheiten weltweit beitragen sollen.

    Find out more about Resistovac.

  • Preplex

    Maschinelles Lernen zur Identifikation molekularer Muster

    Durch maschinelles Lernen sollen im Projekt „PREPLEX“ molekulare Muster identifiziert werden, die einen Hinweis darauf geben, wie Bakterien die Wirkmechanismen von Antibiotika außer Kraft setzen.

    Find out more about Preplex.

  • POCT-ambulant

    Forschungs-Entwicklungs-Praxis-Dialog zur bedarfsgerechten Entwicklung von PoC-Tests

    Mit „POCT-ambulant“ entwickelt der Forschungscampus ein strukturiertes und systematisches Programm zur Beurteilung des Patientennutzens und des klinischen Bedarfes von Vor-Ort-Testverfahren (sogenannten Point-of-Care-Verfahren) im niedergelassenen Bereich.

    Find out more about POCT-ambulant.

  • Screenshot of video

    FastAlert

    Früherkennung von Erregern und Resistenzen in Abwasser

    In „FastAlert“ soll ein Analysesystem zur prozessnahen Erregerdetektion in Abwasseranlagen entstehen, um Infektionserreger und Resistenzgene zu überwachen.

    Find out more about FastAlert.

  • ADA

    Adaptable decentralised diagnostics for veterinary and human medicine

    In the "ADA" project, a cost-effective, open test platform for screening for Staphylococcus aureus / MRSA in human and veterinary medicine is being developed.

    Find out more about ADA.

Partners

Under the maxim "diagnostics before therapy", we successfully realise projects as a public-private partnerships (PPP) with strong partners from industry and science. On the page "partners" you will find an overview of all our campus members.  Here you can first get to know a random selection of our partners: